Data / Form D filings / OyaGen Inc.
OyaGen Inc.: Form D filings
OyaGen Inc., a biotechnology company in Rochester, NY, filed 3 Form D notices with the SEC between 2009 and 2017. The latest, on December 12, 2017, reports $345,000 sold of a $700,000 offering to 11 investors.
Find out what OyaGen Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Rochester BioVenture Center, 77 Ridgeland Road, Rochester, NY, 14623
- Phone
- (585) 697-4351
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1319956
The full lists. Form D filings in New York: 4,357 rows, $123.57, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 12, 2017 | New notice | $700,000 | $345,000 | $355,000 | 11 | Nov 29, 2017 | sec.gov |
| Oct 11, 2012 | New notice | $3,000,000 | $1,742,315 | $1,257,685 | 10 | Sep 28, 2012 | sec.gov |
| Sep 17, 2009 | Amendment | $1,500,000 | $1,029,709 | $470,291 | 12 | Aug 20, 2008 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ryan Bennett | Executive Officer | |
| Richard McCloskey | Director | |
| Thomas Fitzgerald | Executive Officer, Promoter | |
| Richard Ogden | Director | |
| Harold Smith | Executive Officer, Director, Promoter | |
| Roscoe Moore | Director | |
| Kevin Phelps | Executive Officer, Director | |
| Jose Coronas | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Dec 11, 2017 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what OyaGen Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.